Cleared Traditional

K153079 - Axeo 3 Patient Monitor

K153079 is an FDA 510(k) clearance for Axeo 3 Patient Monitor, manufactured by Axeo Medical Technologies, LLC. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 146-day FDA review.

K153079 · Axeo Medical Technologies, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
146d
Days
Class 2
Risk

K153079 is an FDA 510(k) clearance for the Axeo 3 Patient Monitor. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Axeo Medical Technologies, LLC (Palm Harbor, US). The FDA issued a Cleared decision on March 17, 2016 after a review of 146 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Axeo Medical Technologies, LLC devices

FDA 510(k) Submission Details - K153079

510(k) Number K153079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 23, 2015
Decision Date March 17, 2016
Days to Decision 146 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d slower than avg
Panel avg: 125d · This submission: 146d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 175
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K153079.
Truscope Ultra Patient Monitor
K162234 · Guangdong Biolight Meditech Co., Ltd. · Jan 2017
Vital Sync Informatics Manager & Virtual Patient Monitoring Platform
K160718 · Covidien · Nov 2016
Masimo Root Monitoring System and Accessories
K153225 · Masimo Corporation · Jun 2016
VITAL SIGNS MONITOR
K153135 · Guangdong Biolight Meditech Co., Ltd. · Feb 2016
Masimo Root Vital Signs Monitoring System and Accessories
K151644 · Masimo Corporation · Feb 2016
Expression MR400 MRI Patient Monitoring System
K152330 · Invivo Corporation · Dec 2015